Decorative arrowsHMSA Provider Resource Center
HomeNews and AlertsE-LibraryMedicare E-LibraryCommunications ArchiveQUEST Integration
Frequently Asked QuestionsUseful Web SitesContacting HMSA
HMSA Logo
 

AVASTIN (bevacizumab)

Policy Number:
MM.04.001
Original Effective Date:
10/01/2012

 

Avastin (Bevacizumab) - No precertification required for ophthalmic disorders effective 12/01/2018.

 

 

To view the current drug policy, please click the link below:

 

Avastin (Bevacizumab)

 

 

To view previous versions of this policy that are now expired, please click on the links below:

 

Avastin (Bevacizumab) - March 2018

 

Avastin (Bevacizumab) - May 2017

 

Avastin (Bevacizumab) - October 2015

 

Avastin (Bevacizumab) - October 2014

 

 


 

First Published:03/11/2008
Latest Revision:03/07/2019
Back to Top

Files that are in PDF format can be viewed using the free Adobe Reader or another PDF-reader application.

Decorative arrowsHomeNews and AlertsE-LibraryMedicare E-LibraryCommunications ArchiveQUEST IntegrationFrequently Asked QuestionsUseful Web SitesContacting HMSA

Non-discrimination notice

Need a language interpreter?

ʻŌlelo Hawaiʻi | Bisaya | 繁體中文 | Ilokano | 日本語 | 한국어 | ພາສາລາວ | Kajin Ṃajōḷ | Lokaiahn Pohnpei | Gagana Sāmoa | Español | Tagalog | Tonga | Foosun Chuuk | Tiếng Việt